{"id":"https://openalex.org/W2979739655","doi":"https://doi.org/10.1182/blood.v118.21.98.98","title":"A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy Plus Rituximab Vs. CHOP Chemotherapy Plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphoma","display_name":"A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy Plus Rituximab Vs. CHOP Chemotherapy Plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphoma","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2979739655","doi":"https://doi.org/10.1182/blood.v118.21.98.98","mag":"2979739655"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.98.98","doi":"https://doi.org/10.1182/blood.v118.21.98.98","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.98.98","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023180146","display_name":"Oliver W. Press","orcid":"https://orcid.org/0000-0002-3147-8037","observed_orcids":["https://orcid.org/0000-0002-3147-8037"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oliver W. Press","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091192260","display_name":"Joseph M. Unger","orcid":"https://orcid.org/0000-0002-5191-0317","observed_orcids":["https://orcid.org/0000-0002-5191-0317"]},"institutions":[{"id":"https://openalex.org/I4210165553","display_name":"SWOG Cancer Research Network","ror":"https://ror.org/05n6zrm60","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210165553"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joseph M Unger","raw_affiliation_strings":["Statistical Center, Southwest Oncology Group, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Center, Southwest Oncology Group, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210165553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014743270","display_name":"Lisa M. Rimsza","orcid":"https://orcid.org/0000-0003-1268-2750","observed_orcids":["https://orcid.org/0000-0003-1268-2750"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa M. Rimsza","raw_affiliation_strings":["Department of Pathology, University of Arizona, Tucson, AZ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Arizona, Tucson, AZ, USA,","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038526399","display_name":"Jonathan W. Friedberg","orcid":"https://orcid.org/0000-0002-1420-5563","observed_orcids":["https://orcid.org/0000-0002-1420-5563"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Friedberg","raw_affiliation_strings":["James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA,","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041539801","display_name":"Michael Leo LeBlanc","orcid":"https://orcid.org/0000-0001-7192-2860","observed_orcids":["https://orcid.org/0000-0001-7192-2860"]},"institutions":[{"id":"https://openalex.org/I4210165553","display_name":"SWOG Cancer Research Network","ror":"https://ror.org/05n6zrm60","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210165553"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael LeBlanc","raw_affiliation_strings":["Lymphoma Committee, Southwest Oncology Group, San Antonio, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoma Committee, Southwest Oncology Group, San Antonio, TX, USA,","institution_ids":["https://openalex.org/I4210165553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110554446","display_name":"Myron Stefan Czuczman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myron S. Czuczman","raw_affiliation_strings":["Roswell Park Cancer Institute, Buffalo, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Buffalo, NY, USA,","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080366682","display_name":"Mark Stefan Kaminski","orcid":"https://orcid.org/0000-0002-8712-2953","observed_orcids":["https://orcid.org/0000-0002-8712-2953"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark S. Kaminski","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI, USA,","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076637635","display_name":"Rita M. Braziel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rita M. Braziel","raw_affiliation_strings":["Oregon Health and Science Univ., Portland, OR, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science Univ., Portland, OR, USA,","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016684714","display_name":"David G. Maloney","orcid":"https://orcid.org/0000-0002-8477-6919","observed_orcids":["https://orcid.org/0000-0002-8477-6919"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Maloney","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]},{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]},{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce D. Cheson","raw_affiliation_strings":["Division of Hematology and Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA,","institution_ids":["https://openalex.org/I184565670","https://openalex.org/I2799903593","https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102767715","display_name":"Thomas P. Miller","orcid":"https://orcid.org/0000-0002-7100-2682","observed_orcids":["https://orcid.org/0000-0002-7100-2682"]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P. Miller","raw_affiliation_strings":["Arizona Cancer Center, Tucson, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, Tucson, AZ, USA","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111441938","display_name":"Richard I. Fisher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard I Fisher","raw_affiliation_strings":["James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA,","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5041539801","https://openalex.org/A5091192260"],"corresponding_institution_ids":["https://openalex.org/I4210165553"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.8039,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.90102378,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"118","issue":"21","first_page":"98","last_page":"98"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/follicular-non-hodgkin-s-lymphoma","display_name":"follicular non-Hodgkin's lymphoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/chop-chemotherapy","display_name":"CHOP chemotherapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/tositumomab","display_name":"tositumomab","score":0.800000011920929},{"id":"https://openalex.org/keywords/iodine-131","display_name":"iodine-131","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.968999981880188},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6340000033378601},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.3709999918937683},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.5740000009536743},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.816275417804718},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.7161874175071716},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6295742392539978},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.612430989742279},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6049793362617493},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.6000029444694519},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5373588800430298},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49925899505615234},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4546826183795929},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.448927104473114},{"id":"https://openalex.org/C2777607594","wikidata":"https://www.wikidata.org/wiki/Q389496","display_name":"Obinutuzumab","level":4,"score":0.4106607437133789},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4100833833217621},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36395394802093506},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2853206396102905},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.13463237881660461}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.98.98","doi":"https://doi.org/10.1182/blood.v118.21.98.98","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.98.98","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.75,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2293389072","https://openalex.org/W2127682234","https://openalex.org/W2133023691","https://openalex.org/W2058154950","https://openalex.org/W2120247936","https://openalex.org/W4236815493","https://openalex.org/W2587455476","https://openalex.org/W2307133581","https://openalex.org/W4238940234","https://openalex.org/W2974058373"],"abstract_inverted_index":{"Abstract":[0,1],"98":[2],"Background:":[3],"Advanced":[4],"follicular":[5,554],"lymphomas":[6],"(FL)":[7],"are":[8,461,475],"incurable":[9],"with":[10,59,132,194,464,477,483,504,508],"conventional":[11],"chemotherapy":[12,110],"and":[13,29,31,39,67,93,120,148,183,254,310,347,418,473,507],"there":[14],"is":[15,305],"no":[16],"consensus":[17],"on":[18,141,235,261,316,331,343,349,389,402,414,420],"the":[19,37,152,162,166,247,265,284,288,317,332,344,350,361,368,390,403,415,421,430,436,480],"best":[20],"treatment":[21],"approach.":[22],"The":[23,210,335,406],"SWOG":[24],"cancer":[25],"research":[26],"cooperative":[27],"group":[28],"Cancer":[30],"Leukemia":[32],"Group":[33],"B":[34,279],"(CALGB)":[35],"compared":[36,324,395],"safety":[38],"efficacy":[40],"of":[41,86,108,135,165,172,179,191,206,224,228,264,287,312,327,339,386,398,409,479,545,553],"two":[42,285,481],"immunochemotherapy":[43],"regimens":[44,293,482],"for":[45,125,230,241,258,360,371,429,439,491,547],"FL":[46,64,85],"in":[47,283,455,468,518,550],"a":[48,176,188,202,220,236,519],"Phase":[49],"III":[50,81],"randomized":[51],"intergroup":[52],"protocol":[53,523],"(S0016)":[54],"that":[55,525],"enrolled":[56,249],"554":[57,248],"patients":[58,104,168,302],"previously":[60],"untreated,":[61],"advanced":[62,76],"stage":[63,77,79],"between":[65],"3/1/2001":[66],"9/15/2008.":[68],"Methods:":[69],"Pts":[70],"were":[71,252,256,281,294],"eligible":[72,253,314,329,400],"if":[73],"they":[74],"had":[75,94],"(bulky":[78],"II,":[80],"or":[82,91,322,382,458],"IV)":[83],"evaluable":[84,257],"any":[87,97],"grade":[88],"(1,":[89],"2,":[90],"3)":[92],"not":[95,488],"received":[96,105,169],"prior":[98],"therapy.":[99],"In":[100,161,290,355,424],"one":[101],"arm":[102,164,263,319,346,352,392,417],"(CHOP-R),":[103],"6":[106,133,170],"cycles":[107,171],"CHOP":[109],"(750":[111],"mg/m2":[112,115,118,140],"cyclophosphamide,":[113],"50":[114],"doxorubicin,":[116],"1.4":[117],"vincristine,":[119],"100":[121],"mg":[122],"prednisone":[123],"daily":[124],"5":[126],"days)":[127],"at":[128],"3":[129,242],"week":[130],"intervals":[131],"doses":[134],"rituximab":[136,510],"anti-CD20":[137],"antibody":[138],"(375":[139],"days":[142],"1,":[143],"6,":[144],"48,":[145],"90,":[146],"134":[147],"141":[149],"according":[150],"to":[151,200,214,218,226,325,396,486,499],"schedule":[153],"described":[154],"by":[155,175],"Czuczman":[156],"et":[157],"al.[J.Clin.Oncol":[158],"17:268,":[159],"1999]).":[160],"second":[163],"protocol,":[167],"CHOP,":[173],"followed":[174],"dosimetric":[177],"infusion":[178,190],"tositumomab/iodine":[180],"I-131":[181,196],"tositumomab":[182],"then":[184],"1\u20132":[185],"weeks":[186],"later":[187],"therapeutic":[189],"I-131-tositumomab":[192,546],"labeled":[193],"sufficient":[195],"(median":[197],"85":[198],"mCi)":[199],"deliver":[201],"total":[203],"body":[204],"dose":[205],"75":[207],"cGy":[208],"(CHOP-RIT).":[209],"study":[211],"was":[212,341,375,412,443],"designed":[213],"have":[215,320,393],"86%":[216],"power":[217],"detect":[219],"hazard":[221,369,437],"ratio":[222,370,438],"(HR)":[223],"CHOP-RIT":[225,333,351,372,404,422,440],"CHOP-R":[227,318,345,374,391,416,442,503],"0.67":[229],"2":[231,274,336],"yr":[232],"PFS":[233,340,472],"based":[234],"one-sided.021":[237],"level":[238],"test":[239],"(accounting":[240],"interim":[243],"analyses).":[244],"Results:":[245],"Of":[246],"pts,":[250],"532":[251],"526":[255],"toxicity":[259],"(263":[260],"each":[262],"protocol).":[266],"Pt":[267],"characteristics":[268],"(age,":[269],"sex,":[270],"race,":[271],"stage,":[272],"beta":[273],"microglobulin":[275,366],"level,":[276],"tumor":[277],"bulk,":[278],"symptoms)":[280],"well-balanced":[282],"arms":[286],"protocol.":[289],"general,":[291],"both":[292],"well-tolerated":[295],"(Table":[296],"I).":[297],"Median":[298],"follow-up":[299,520],"time":[300],"among":[301],"still":[303],"alive":[304],"4.9":[306],"years.":[307],"One":[308],"hundred":[309],"six":[311],"267":[313,387],"pts":[315,330,388,401],"progressed":[321],"died":[323,394],"86":[326],"265":[328,399],"arm.":[334,405,423],"year":[337],"estimate":[338,408],"76%":[342],"80%":[348],"(Figure":[353],"1).":[354],"multivariate":[356,425],"Cox":[357,426],"regression":[358,427],"adjusting":[359,428],"stratification":[362,431],"factor":[363,432],"(serum":[364],"beta-2":[365,434],"level),":[367],"vs.":[373,441],"0.79":[376],"(95%":[377,445],"CI:":[378,446],"0.60\u20131.05,":[379],"p=.11":[380],"[2-sided]":[381],"p=.06":[383],"[1-sided]).":[384],"Twenty-six":[385],"40":[397],"2-year":[407],"overall":[410],"survival":[411],"97%":[413],"93%":[419],"serum":[433],"microglobulin,":[435],"1.55":[444],"0.95\u20132.54,":[447],"p=.08":[448],"[2-sided]).":[449],"Conclusion:":[450],"No":[451],"statistically":[452],"significant":[453],"differences":[454],"PFS,":[456],"OS,":[457],"serious":[459],"toxicities":[460],"yet":[462,489],"demonstrable":[463],"either":[465,478,492],"regimen":[466],"administered":[467],"this":[469],"trial.":[470],"However,":[471],"OS":[474],"outstanding":[476],"median":[484],"times":[485],"progression":[487],"reached":[490],"treatment.":[493],"Future":[494],"studies":[495],"will":[496,511],"be":[497],"needed":[498],"assess":[500],"whether":[501],"combining":[502],"RIT":[505],"consolidation":[506,548],"maintenance":[509],"confer":[512],"additive":[513],"benefit,":[514],"as":[515],"being":[516],"evaluated":[517],"trial":[521],"(SWOG":[522],"S0801)":[524],"has":[526],"recently":[527],"completed":[528],"accrual.":[529],"Disclosures:":[530],"Press:":[531],"Spectrum:":[532],"Consultancy,":[533,536,557,562,566,575,582,592],"Honoraria;":[534],"Roche/Genentech:":[535],"Honoraria,":[537,576,583],"Research":[538,563,589],"Funding.":[539,590],"Off":[540],"Label":[541],"Use:":[542],"Front-line":[543],"use":[544],"therapy":[549],"1st":[551],"remission":[552],"lymphoma.":[555],"Friedberg:Genentech:":[556],"Honoraria.":[558,567,593],"Czuczman:Glaxo":[559],"Smith":[560,569,580,587],"Kline:":[561,570,581,588],"Funding;":[564],"Genentech:":[565],"Kaminski:Glaxo":[568],"Patents":[571],"&":[572],"Royalties.":[573],"Maloney:Genentech/Roche:":[574],"Speakers":[577,584],"Bureau;":[578],"Glaxo":[579],"Bureau.":[585],"Cheson:Glaxo":[586],"Fisher:Roche:":[591]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":11}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}